2020 Pediatric Grand Rounds | Functional Genomics in High-risk Renal Tumors
Therapies for childhood kidney tumors have been limited due to the lack of models and the limited identification of new therapeutic targets. An overview of recent methodologies will generate such models and show how functional genomics can be used to help identify new potential therapies.
Because of the rarity of renal tumors in children, exposure to cases is limited. This CME activity is the evolution of the studies in renal tumors and will enhance the understanding/treatment of these rare tumors. There has been very good progress in many renal tumors with chemotherapy regimens but we have reached a plateau and new molecular targets will allow improved outcome in children with renal tumors just as targeted therapy has improved outcome in adult tumors (e.g. lung cancer).
Pediatric Hematology/Oncology Physicians, Advance Practice Practitioners, staff and research team.
- Discuss the state of renal tumor biology research.
- Outline the background of functional genomics and discuss how it leads to targeted therapies for tumors in general.
- Identify specific therapy that exploits renal tumor biology based upon functional genomics.
- Outline the various types of cultural diversities (gender, age, race, religion, culture, etc.) that relate to demographics, diagnosis and treatment.
Virtual Meeting- Zoom
Andrew Hong, MD Pediatric Hematologist/Oncologist, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta; Assistant Professor, Department of Pediatrics; Emory University School of Medicine
Dr. Hong has indicated that he does not have anything to disclose.
Dr. Hong will be discussing the off-label or investigational use of bortezomib, ixazomib, and selinexor.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2020 Pediatric Grand Rounds | Functional Genomics in High-risk Renal Tumors for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance